Life ScienceCompany
Who owns SERB Pharmaceuticals?
SERB Pharmaceuticals is owned by Charterhouse Capital Partners and Merieux Equity Partners. It was acquired in 2017.
SERB Pharmaceuticals is owned by Charterhouse Capital Partners and Merieux Equity Partners. It was acquired in 2017.
8 rue Beaumont,
Luxembourg,
1219
Luxembourg,
+352 26 20 12 16
www.serb.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2017-06-09 | Merieux Equity Partners, Charterhouse Capital Partners | |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
